Intrinsic Value of S&P & Nasdaq Contact Us

DaVita Inc. DVA NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$360.50
+141.2%
Analyst Price Target
$168.67
+12.9%

DaVita Inc. (DVA) is a publicly traded company in the Healthcare sector, operating within the Medical - Care Facilities industry. The company is headquartered in Denver, CO, United States. The current CEO is Javier J. Rodriguez.

DVA has IPO date of 1995-10-31, 76,000 full-time employees, listed on the NYSE, a market capitalization of $9.99B.

About DaVita Inc.

DaVita Inc. is a leading provider of kidney dialysis and related renal care services, operating a global network of outpatient dialysis centers and providing comprehensive treatment solutions for patients with chronic kidney failure and end-stage renal disease. The company operates approximately 2,815 dialysis centers across the United States serving around 203,100 patients, along with 339 centers in ten countries internationally serving approximately 39,900 patients. Beyond dialysis services, DaVita offers clinical laboratory testing, vascular access services, disease management programs, acute inpatient dialysis services in approximately 850 hospitals, and integrated care arrangements for thousands of patients. The company also operates clinical laboratories and provides physician services and comprehensive kidney care management. Headquartered in Denver, Colorado, DaVita Inc. is a major player in the nephrology care market, delivering both clinical and administrative services to support patients with serious kidney conditions.

📍 2000 16th Street, Denver, CO 80202 📞 720 631 2100
Company Details
SectorHealthcare
IndustryMedical - Care Facilities
CountryUnited States
ExchangeNYSE
CurrencyUSD
IPO Date1995-10-31
CEOJavier J. Rodriguez
Employees76,000
Trading Info
Current Price$149.45
Market Cap$9.99B
52-Week Range101-159.42
Beta0.93
ETFNo
ADRNo
CUSIP23918K108
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message